Inovio Pharmaceuticals Inc (INO)

Inovio Pharmaceuticals Inc (INO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $102M; returns 1 day +6.9%, 1 week -9.4%, 1 year -60.1%.

Inovio Pharmaceuticals, Inc. (INO) is a clinical-stage biotechnology company specializing in the development of DNA medicines using its proprietary DNA plasmid platform, including devices like CELLECTRA for electroporation delivery.

Groups INO belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Immunotherapy
• Life Sciences
• Biopharmaceutical
• Oncology
• Cancer Therapeutics

INO financial model: income statement, cash flow and balance sheet